×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Nancy Lurker

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerDirectorNov 26, 2025Sale$14.952002,990216,347Dec 01, 2025, 04:09 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerDirectorNov 28, 2025Sale$14.955007,475215,847Dec 01, 2025, 04:09 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerDirectorJul 10, 2025Option/RSU Exercise-11,111-216,547Jul 11, 2025, 04:06 PM
ALKSAlkermes plc.Nancy LurkerDirectorMay 31, 2025Tax Payment (Shares)$30.611,92458,89410,705Jun 02, 2025, 04:31 PM
ALKSAlkermes plc.Nancy LurkerDirectorMay 31, 2025Option/RSU Exercise-8,013-12,629Jun 02, 2025, 04:31 PM
ALKSAlkermes plc.Nancy LurkerDirectorApr 11, 2025Tax Payment (Shares)$27.001,45939,3934,616Apr 14, 2025, 05:17 PM
ALKSAlkermes plc.Nancy LurkerDirectorApr 11, 2025Option/RSU Exercise-6,075-5,517Apr 14, 2025, 05:17 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerDirectorFeb 09, 2025Option/RSU Exercise-20,000-205,436Feb 11, 2025, 06:19 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerDirectorJan 05, 2025Option/RSU Exercise-12,667-110,302Jan 07, 2025, 04:04 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerDirectorJan 06, 2025Option/RSU Exercise-75,134-185,436Jan 07, 2025, 04:04 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerDirectorAug 16, 2024Buy$7.883,17325,00397,635Aug 20, 2024, 04:04 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerExecutive Vice ChairJul 10, 2024Option/RSU Exercise-11,111-94,462Jul 12, 2024, 05:03 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerExecutive Vice ChairFeb 09, 2024Option/RSU Exercise-37,534-172,975Feb 13, 2024, 05:40 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerExecutive Vice ChairFeb 13, 2024Gift-74,681-83,351Feb 13, 2024, 05:40 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerExecutive Vice ChairFeb 13, 2024Gift-74,681-126,889Feb 13, 2024, 05:40 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerExecutive Vice ChairFeb 09, 2024Tax Payment (Shares)$28.8014,943430,358165,013Feb 13, 2024, 05:40 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerExecutive Vice ChairJan 23, 2024Sale$24.975,044125,950165,397Jan 25, 2024, 06:24 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerExecutive Vice ChairJan 24, 2024Sale$24.9829,956748,250135,441Jan 25, 2024, 06:24 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerExecutive Vice ChairJan 06, 2024Tax Payment (Shares)$20.4023,043470,077170,441Jan 09, 2024, 09:17 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerExecutive Vice ChairJan 06, 2024Option/RSU Exercise-75,133-193,484Jan 09, 2024, 09:17 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerExecutive Vice ChairDec 28, 2023Gift-52,208-52,208Jan 03, 2024, 06:37 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerExecutive Vice ChairDec 28, 2023Gift-52,208-118,351Jan 03, 2024, 06:37 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerExecutive Vice ChairDec 04, 2023Sale$20.7620,000415,200170,559Dec 06, 2023, 05:18 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerCEOFeb 09, 2023Option/RSU Exercise-37,533-190,559Feb 13, 2023, 04:56 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerPresident & CEOFeb 28, 2022Option/RSU Exercise-12,466-150,281Mar 02, 2022, 06:21 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerPresident & CEOFeb 21, 2022Option/RSU Exercise-13,717-137,815Feb 23, 2022, 04:13 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerPresident & CEOFeb 09, 2022Option/RSU Exercise-17,533-124,098Feb 11, 2022, 04:38 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerPresident & CEONov 15, 2021Sale$20.1510,000201,480103,546Nov 17, 2021, 05:03 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerPresident & CEOJun 14, 2021Option/RSU Exercise-4,500-113,546Jun 15, 2021, 05:04 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerPresident & CEOFeb 28, 2021Option/RSU Exercise-12,467-109,046Mar 02, 2021, 07:21 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerPresident & CEOFeb 21, 2021Option/RSU Exercise-13,717-96,579Feb 23, 2021, 09:01 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerPresident & CEOJun 30, 2020Option/RSU Exercise-124,667-784,467Jul 02, 2020, 06:13 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerPresident & CEOJun 27, 2020Option/RSU Exercise-40,000-659,800Jun 30, 2020, 07:40 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerPresident & CEOJun 14, 2020Option/RSU Exercise-45,000-619,800Jun 16, 2020, 05:03 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerPresident & CEOMar 10, 2020Buy$1.0698,000104,027574,800Mar 11, 2020, 08:40 AM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerPresident & CEOFeb 21, 2020Option/RSU Exercise-137,174-476,800Feb 25, 2020, 04:50 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerPresident & CEOOct 12, 2019Tax Payment (Shares)$2.1110,74522,618314,455Oct 15, 2019, 06:04 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerPresident & CEOJun 27, 2019Option/RSU Exercise-40,000-325,200Jun 28, 2019, 05:03 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerPresident & CEOJun 14, 2019Option/RSU Exercise-45,000-285,200Jun 17, 2019, 05:42 PM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerPresident & CEOMar 29, 2019Buy$1.7628,50050,246240,200Apr 01, 2019, 08:23 AM
EYPTEyePoint Pharmaceuticals, Inc.Nancy LurkerPresident & CEOJun 27, 2018Option/RSU Exercise-40,000-135,033Jun 29, 2018, 04:00 PM
PSDVpSivida Corp.Nancy LurkerPresident and CEOJun 14, 2017Buy$1.7656,70099,96256,700Jun 14, 2017, 04:05 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe